Recital 4, Regulation (EU) 2026/473

In forcesince 14 Oct 2025

Consequently, for the uses of the biocidal product family belonging to product-type 4 the condition for authorisation of Article 19(1), point (a), of Regulation (EU) No 528/2012 requiring that the active substances are included in Annex I or approved for the relevant product-type and any conditions specified for those active substances are met, will not be fulfilled as of 1 September 2025.